Collaborators

Linda Griffith, PhD Linda Griffith's laboratory (M.I.T.) attempts to understand and control cell interactions with surfaces with a focus on applications in tissue engineering and cell culture. Projects encompass two complementary areas: synthesis and modification of polymeric materials, and characterization of cell and tissue responses to materials.
Rick Horwitz, PhD Rick Horwitz's laboratory (University of Virginia) is actively investigating many aspects of the structure and function of integrin molecules and the processes they mediate. Recent progress includes elucidation of the roles of several different integrins during (muscle) differentiation.
Roger Kamm, PhD Roger Kamm's research (M.I.T.) includes biomedical fluid dynamics such as repiratory mechanics, ocular fluid dynamics and transport, and cardiovascular fluid dynamics. Models of normal and pathologic conditions are used to elucidate mechanical phenomena.
Bruce Tidor, PhD Bruce Tidor
Peter Sorger, PhD Peter Sorger
Alan Wells, PhD Alan Wells' laboratory researches growth factor receptor-mediated cell locomotion and its consequences in physiologic and pathologic situations. The laboratory is investigating motility signaling from the epidermal growth factor receptor (EGFR) as our model system.
Steve Wiley, PhD Steve Wiley's research interests have focused on understanding mechanisms of cell communication and signaling using the epidermal growth factor receptor (EGFR) system as a model. He pioneered methods for the quantitative analysis of receptor dynamics in mammalian cells and published some of the first computer models of receptor regulation. He has been a major contributor to the field of receptor research, particularly with regard to the control of receptor distribution within cells.
Dane Wittrup, PhD Dane Wittrup's lab develops protein engineering technology and applies it to the discovery of new biopharmaceuticals. In particular, yeast surface display is used for the directed evolution of protein expression stability, affinity, and specificity.  A particular focus is on the development of anti-cancer drugs, with quantitative studies of cellular-level pharmacokinetics and pharmacodynamics.
Michael Yaffe, PhD Michael Yaffe

 

top